UBS Group’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.4M | Buy |
|
|||||
|
2025
Q1 | $17.7M | Sell |
|
|||||
|
2024
Q4 | $32.9M | Buy |
|
|||||
|
2024
Q3 | $17.1M | Buy |
|
|||||
|
2024
Q2 | $2.04M | Buy |
|
|||||
|
2024
Q1 | $1.21M | Sell |
|
|||||
|
2023
Q4 | $1.05M | Buy |
|
|||||
|
2023
Q3 | $359K | Sell |
|
|||||
|
2023
Q2 | $1.73M | Buy |
|
|||||
|
2023
Q1 | $465K | Buy |
|
|||||
|
2022
Q4 | $274K | Buy |
|
|||||
|
2022
Q3 | $1K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $14K | Sell |
|
|||||
|
2021
Q4 | $273K | Buy |
|
|||||
|
2021
Q3 | $53K | Sell |
|
|||||
|
2021
Q2 | $83K | Sell |
|
|||||
|
2021
Q1 | $144K | Sell |
|
|||||
|
2020
Q4 | $145K | Sell |
|
|||||
|
2020
Q3 | $226K | Sell |
|
|||||
|
2020
Q2 | $581K | Buy |
|
|||||
|
2020
Q1 | $311K | Sell |
|
|||||
|
2019
Q4 | $937K | Buy |
|
|||||
|
2019
Q3 | $706K | Buy |
|
|||||
|
2019
Q2 | $353K | Buy |
|
|||||
|
2019
Q1 | $8K | Sell |
|
|||||
|
2018
Q4 | $10K | Sell |
|
|||||
|
2018
Q3 | $99K | Buy |
|
|||||
|
2018
Q2 | $45K | Sell |
|
|||||
|
2018
Q1 | $88K | Buy |
|
|||||
|
2017
Q4 | $19K | Sell |
|
|||||
|
2017
Q3 | $147K | Buy |
|
|||||
|
2017
Q2 | $105K | Sell |
|
|||||
|
2017
Q1 | $228K | Sell |
|
|||||
|
2016
Q4 | $418K | Sell |
|
|||||
|
2016
Q3 | $1.28M | Buy |
|
|||||
|
2016
Q2 | $812K | Buy |
|
|||||
|
2016
Q1 | $65K | Sell |
|
|||||
|
2015
Q4 | $88K | Buy |
|
|||||
|
2015
Q3 | $2K | Sell |
|
|||||
|
2015
Q2 | $537K | Buy |
|
|||||
|
2015
Q1 | $170K | Buy |
|
|||||
|
2014
Q4 | $42K | Buy |
|